Literature DB >> 21787779

Absolute and percent CD4+ T-cell enumeration by flow cytometry using capillary blood.

Nádia Sitoe1, Ellen Luecke, Nelson Tembe, Raquel Matavele, Victoria Cumbane, Eugénia Macassa, Paula Vaz, Haynes Sheppard, Ilesh V Jani.   

Abstract

INTRODUCTION: CD4+ T-cell counting is usually performed on whole blood obtained from standard venipuncture. Venipuncture requires expertise, results in discomfort and generates biological waste. Capillary blood could be used to measure the levels of CD4+ T-cell in children, elderly and very ill patients. We studied the agreement between CD4+ T-cell counts and percent generated using venous blood with those obtained with capillary blood in HIV-infected adults and children in a resource-limited tropical setting.
METHODS: This cross-sectional study consecutively enrolled a total of 152 adult and pediatric HIV-positive patients attending two outpatient clinics in Maputo City, Mozambique. We recruited individuals presenting for their routine clinical follow-up that included the determination of CD4+ T-cell counts in peripheral blood. For each subject, peripheral blood specimens were obtained by both venipuncture and finger prick. Specimens were tested using two flow cytometers, the FACSCount and the FACSCalibur.
RESULTS: Absolute CD4+ T-cell counts obtained using capillary blood were in close agreement with those from venous blood both on the FACSCalibur (absolute bias=+12.3 cells/mm³, limits of agreement: -259.2 to +283.9, R²=0.96) and the FACSCount (absolute bias=+16.1 cells/mm³, limits of agreement: -209.2 to +241.5, R²=0.97). Percent CD4+ T-cell counts were measured only on the FACSCalibur also showed a good agreement with a bias of +0.6% and limits of agreement of -3.1 to +4.3.
CONCLUSIONS: Absolute CD4+ T-cell counts and percent generated using capillary blood are in close agreement with those from venous blood. Point-Of-Care assays and standard flow cytometers can be deployed in a tiered laboratory network where both venous and capillary blood collection can be used for CD4+ T-cell enumeration.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21787779     DOI: 10.1016/j.jim.2011.07.008

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  14 in total

1.  Comparison of capillary and venous blood in the analysis of concentration and function of leucocyte sub-populations.

Authors:  Elisa F D Canetti; J Keane; C P McLellan; A B Gray
Journal:  Eur J Appl Physiol       Date:  2016-06-15       Impact factor: 3.078

2.  Low-cost tools for diagnosing and monitoring HIV infection in low-resource settings.

Authors:  Grace Wu; Muhammad H Zaman
Journal:  Bull World Health Organ       Date:  2012-10-19       Impact factor: 9.408

3.  Performance evaluation of the Pima™ point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa.

Authors:  Deborah K Glencross; Lindi M Coetzee; Mamsallah Faal; Martin Masango; Wendy S Stevens; Wd Francois Venter; Regina Osih
Journal:  J Int AIDS Soc       Date:  2012-01-30       Impact factor: 5.396

Review 4.  CD4 enumeration technologies: a systematic review of test performance for determining eligibility for antiretroviral therapy.

Authors:  Rosanna W Peeling; Kimberly A Sollis; Sarah Glover; Suzanne M Crowe; Alan L Landay; Ben Cheng; David Barnett; Thomas N Denny; Thomas J Spira; Wendy S Stevens; Siobhan Crowley; Shaffiq Essajee; Marco Vitoria; Nathan Ford
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

5.  Clinical Evaluation of the BD FACSPresto™ Near-Patient CD4 Counter in Kenya.

Authors:  Francis Angira; Benta Akoth; Paul Omolo; Valarie Opollo; Scott Bornheimer; Kevin Judge; Henok Tilahun; Beverly Lu; Imelda Omana-Zapata; Clement Zeh
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

6.  CD4 Lymphocyte Enumeration and Hemoglobin Assessment Aid for Priority Decisions: A Multisite Evaluation of the BD FACSPresto System.

Authors:  Madhuri Thakar; Francis Angira; Kovit Pattanapanyasat; Alan H B Wu; Maurice O'Gorman; Hui Zeng; Chenxue Qu; Bharati Mahajan; Kasama Sukapirom; Danying Chen; Yu Hao; Yan Gong; Monika De Arruda Indig; Sharon Graminske; Diana Orta; Nicole d'Empaire; Beverly Lu; Imelda Omana-Zapata; Clement Zeh
Journal:  Open AIDS J       Date:  2017-10-24

7.  Evaluation of Specimen Types for Pima CD4 Point-of-Care Testing: Advantages of Fingerstick Blood Collection into an EDTA Microtube.

Authors:  Luciana Kohatsu; Omotayo Bolu; Mary E Schmitz; Karen Chang; Ruth Lemwayi; Nichole Arnett; Michael Mwasekaga; John Nkengasong; Fausta Mosha; Larry E Westerman
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

8.  Field Performance and Diagnostic Accuracy of a Low-Cost Instrument-Free Point-of-Care CD4 Test (Visitect CD4) Performed by Different Health Worker Cadres among Pregnant Women.

Authors:  Stanley Luchters; Karl Technau; Yasmin Mohamed; Matthew F Chersich; Paul A Agius; Minh D Pham; Mary L Garcia; James Forbes; Andrew Shepherd; Ashraf Coovadia; Suzanne M Crowe; David A Anderson
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

Review 9.  Point of Care Technologies for HIV.

Authors:  Mohan Kumar Haleyur Giri Setty; Indira K Hewlett
Journal:  AIDS Res Treat       Date:  2014-01-21

Review 10.  Spinning straw into gold: description of a disruptive rheumatology research platform inspired by the COVID-19 pandemic.

Authors:  S W Tas; G J Wolbink; L Boekel; F Hooijberg; E H Vogelzang; P L Klarenbeek; W H Bos
Journal:  Arthritis Res Ther       Date:  2021-08-05       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.